Search Results - "Ver Donck, K."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Nucleoside transport inhibition and fMLP-stimulated whole blood luminescence by Ver Donck, K L, Verheyen, W J, Van Belle, H

    “…Adenosine (ADO) has a pharmacological profile which makes it an interesting 'drug' to handle many of the problems arising with ischemia and reperfusion. In…”
    Get more information
    Journal Article
  2. 2

    Structural interpretation of the amino acid sequence of a second domain from the Artemia covalent polymer globin by MOENS, L, VAN HAUWAERT, M.-L, DE SMET, K, VER DONCK, K, VAN DE PEER, Y, VAN BEEUMAN, J, WODAK, S, ALARD, P, TROTMAN, C

    Published in The Journal of biological chemistry (25-08-1990)
    “…Artemia has a complex extracellular hemoglobin of Mr 260,000 comprising two globin chains (Mr 130,000) each of which is a polymer of eight covalently linked…”
    Get full text
    Journal Article
  3. 3

    Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection by Rongen, G A, Smits, P, Ver Donck, K, Willemsen, J J, De Abreu, R A, Van Belle, H, Thien, T

    Published in The Journal of clinical investigation (01-02-1995)
    “…In 12 healthy male volunteers (27-53 yr), a placebo-controlled randomized double blind cross-over trial was performed to study the effect of the intravenous…”
    Get full text
    Journal Article
  4. 4

    The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine by SNOECK, E, JACQMIN, P, HEYKANTS, J, VAN PEER, A, DANHOF, M, VER DONCK, K, VAN BELLE, H, WOESTENBORGHS, R, CRABBE, R, VAN GOOL, R, DUPONT, A

    Published in British journal of clinical pharmacology (01-11-1996)
    “…1. Draflazine, a nucleoside transport inhibitor, was administered as a 15 min i.v. infusion of 2.5 mg to eight healthy male subjects. Plasma and whole blood…”
    Get full text
    Conference Proceeding Journal Article
  5. 5
  6. 6

    Role of nucleoside transport inhibition and endogenous adenosine in prevention of catecholamine induced death in rabbits by Van Belle, H, Ver Donck, K, Verheyen, W

    Published in Cardiovascular research (01-01-1993)
    “…R 75,231, a potent and specific nucleoside transport inhibitor, largely prevents cardiac damage and death in catecholamine challenged rabbits. The major…”
    Get more information
    Journal Article
  7. 7

    Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazine by Snoeck, E, Ver Donck, K, Jacqmin, P, Van Belle, H, Dupont, A G, Van Peer, A, Danhof, M

    “…A physiological red blood cell (RBC) kinetic model is proposed for the adenosine (ADO) transport into erythrocytes and its subsequent intracellular deamination…”
    Get more information
    Journal Article
  8. 8
  9. 9

    The implications of non‐linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine by SNOECK, E., JACQMIN, P., PEER, A., DANHOF, M., DONCK, K., BELLE, H., WOESTENBORGHS, R., CRABBÉ, R., GOOL, R., DUPONT, A., HEYKANTS, J.

    Published in British journal of clinical pharmacology (01-11-1996)
    “…1 Draflazine, a nucleoside transport inhibitor, was administered as a 15 min i.v. infusion of 2.5 mg to eight healthy male subjects. Plasma and whole blood…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Prevention of catecholamine-induced cardiac damage and death with a nucleoside transport inhibitor by Van Belle, H, Verheyen, W, Ver Donck, K, Janssen, P A, Robertson, J I

    Published in Journal of cardiovascular pharmacology (01-08-1992)
    “…The effect of a potent and specific nucleoside transport inhibitor, R 75,231, on catecholamine-induced cardiac toxicity has been studied in rabbits…”
    Get more information
    Journal Article
  12. 12

    High-grade nucleoside transport inhibition stimulates ventilation in humans by Rongen, G A, Smits, P, Bootsma, G, Ver Donck, K, de Vries, A, Thien, T

    Published in Journal of clinical pharmacology (01-04-1995)
    “…In 6 healthy male volunteers a placebo-controlled, double-blind, randomized, crossover trial was done to assess the effect of 1, 2, 4, and 6 mg of draflazine,…”
    Get more information
    Journal Article
  13. 13

    Purine metabolism in the heart. Strategies for protection against myocardial ischaemia by Ver Donck, K

    Published in Pharmacy world and science (15-04-1994)
    “…Adenosine has recently received much attention for the protection it provides against the deleterious effects of ischaemia reperfusion. Whenever the demand for…”
    Get more information
    Journal Article